Prostate cancer

Obiettivo della formazione: Identify patients who are likely to benefit from different options of androgen deprivation therapy (ADT), evaluate the benefits, risks and limitations, and develop optimal personalised treatment strategies.

Specializzazione: Urology, Medical oncology, Radiation oncology

Pubblico target: CME (basic-intermediate), Residents (senior)

Aggiornamento più recente: August 2023

Premessa:

For more than 8 decades, ADT has been playing an important role in advanced prostate cancer (PCa) treatment. Nevertheless, understanding and optimising this therapy is still challenging. With different ADT options varying in administration route and adverse event profiles, healthcare providers are challenged with choosing the most optimal treatment for specific patient populations. In addition, great differences exist among the patients’ personal preferences regarding the treatment choice. This should be taken into account during shared decision-making and personalisation of the ADT, together with maximising benefit and minimising harm to the patients.